Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Chronic Atrophic Acrodermatitis
NCT02147262Unknown
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jul 2013
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of doxycycline in Acrodermatitis chronica atrophicans (ACA), sponsored by University Medical Centre Ljubljana. Primary endpoint: Inflammatory proteins at 24 months. Status: unknown.
02
Drugs
doxycycline
03
Conditions
Acrodermatitis chronica atrophicans (ACA)
Beyond the preview
Go deeper on NCT02147262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147262.